GlassScriptPhysician profile
Christopher P Silveri
NPI 1982693032
$183,746.78
in general payments reported to CMS, 2019-2025
19 companies · $37K in 2025
The $37K reported for 2025 was more than what 94% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $10K · 2020: $7,537 · 2021: $17K · 2022: $31K · 2023: $40K · 2024: $41K · 2025: $37K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $116K · Travel and Lodging: $947 · Royalty Or License: $554 · Food and Beverage: $467.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $116,168.75 |
| Travel and Lodging | $946.74 |
| Royalty Or License | $553.56 |
| Food and Beverage | $466.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arteriocyte Medical Systems, INC. | $155,397.55 | 2019-2025 | Magellan, Influx |
| Globus Medical, INC. | $12,461.39 | 2019-2025 | Elsa, Alif, Unify / Assure-X |
| Medical Device Business Services, INC. | $8,715.34 | 2019-2021 | |
| Medtronic USA, INC. | $3,671.61 | 2019-2020 | |
| Medtronic, INC. | $934.27 | 2021-2022 | |
| Ethicon INC. | $877.50 | 2020 | |
| Depuy Synthes Sales INC. | $454.20 | 2019-2021 | |
| Depuy Synthes Products, INC. | $425.90 | 2021 | |
| Organogenesis INC. | $175.20 | 2020 | |
| Pacira Pharmaceuticals Incorporated | $153.10 | 2019-2021 | |
| Cerapedics INC. | $148.75 | 2020 | |
| Stryker Corporation | $143.91 | 2019 | |
| Prosidyan, INC | $88.54 | 2019-2021 | |
| Pacira Therapeutics, INC. | $44.00 | 2021 | |
| Wright Medical Technology, INC. | $14.78 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $12.62 | 2019 | |
| Providence Medical Technology, INC. | $12.29 | 2019 | |
| Orthofix Medical, INC. | $9.95 | 2019 | |
| Surgalign Spine Technologies, INC. | $5.88 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Silveri listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.